Amidst the shortage of Remdesivir in India, the vital drug used to treat the Covid-19, the Centre has started importing from other countries to ease out the shortage.
The first consignment of 75,000 vials will reach India today, the Ministry of Chemicals and Fertilisers said in a statement on Friday
HLL Lifecare Ltd, a government company, has ordered 4,50,000 vials of Remdesivir from Gilead Sciences Inc. USA and Egyptian pharma company Eva Pharma. It is expected that Gilead Sciences Inc USA will dispatch 75,000 to 1,00,000 vials in the next one or two days. Further 100,000 vials will also be supplied before or by May 15. Eva Pharma will supply about 10,000 vials initially followed by 50,000 vials every 15 days or till July.
The government had also prohibited the export of Remdesivir to enhance its availability in India. To ensure affordability of the injection among the masses, the National Pharmaceutical Pricing Authority (NPPA) had on April 17 released the revised maximum retail price thus bringing down the cost of all the major brands to below ₹3,500 per viral.
There are also emergency Covid-19 relief shipment from the US, worth more than $100 million including large oxygen generation systems and raw material for making 20 million vaccine doses to support India’s fight against second wave of Covid-19 infections. It include 200 size D oxygen cylinders with regulators, 223 size H oxygen cylinders with regulators, 210 pulse oximeter, 1,84,000 test kits and 84,000 N95 face marks.
India is also expecting support from over 40 countries in the form of oxygen related equipment and medicines in surge of infection. Also it will receive 157 ventilators, 480 BiPAPs and other medical supplies from the UAE and Romania will cover 80 oxygen concentrators and 75 oxygen cylinders.